Literature DB >> 18090296

Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naïve patient treated for chronic HBV.

Mamta K Jain, Cindy L Zoellner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090296     DOI: 10.1097/QAD.0b013e3282f1e769

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

Review 1.  Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

Authors:  Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong
Journal:  Can J Hosp Pharm       Date:  2012-03

Review 3.  Antiviral therapies: focus on hepatitis B reverse transcriptase.

Authors:  Eleftherios Michailidis; Karen A Kirby; Atsuko Hachiya; Wangdon Yoo; Sun Pyo Hong; Soo-Ok Kim; William R Folk; Stefan G Sarafianos
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

Review 4.  Entecavir: a review of its use in chronic hepatitis B.

Authors:  Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

5.  Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humans.

Authors:  Noortje M van Maarseveen; Annemarie Mj Wensing; Dorien de Jong; Greg L Beilhartz; Aleksandr Obikhod; Sijia Tao; Marieke Pingen; Joop E Arends; Andy Im Hoepelman; Raymond F Schinazi; Matthias Götte; Monique Nijhuis
Journal:  Antivir Ther       Date:  2011

6.  The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients.

Authors:  Joe Sasadeusz; Jennifer Audsley; Anne Mijch; Rachel Baden; Jose Caro; Hermeyone Hunter; Gail Matthews; Moira A McMahon; Susan A Olender; Robert F Siliciano; Sharon R Lewin; Chloe L Thio
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

Review 7.  Evaluation and treatment of the patient coinfected with hepatitis B and HIV.

Authors:  Ellen Kitchell; Mamta K Jain
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

Review 8.  Management of hepatitis B virus co-infection on and off antiretroviral therapy.

Authors:  Vincent Soriano; Eugenia Vispo; Marcelle Bottecchia; Julie Sheldon; Paula Tuma; Javier Garcia-Samaniego; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

Review 9.  New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.

Authors:  Moira A McMahon; Lin Shen; Robert F Siliciano
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

10.  Antiviral treatment of chronic hepatitis B virus (HBV) infections.

Authors:  Erik De Clercq; Geoffrey Férir; Suzanne Kaptein; Johan Neyts
Journal:  Viruses       Date:  2010-05-31       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.